InVivoMab anti-mouse PD-L1 (B7-H1)

Catalog number: BE0101_100mg
Brand: Bio X Cell
Packing: 100 mg
Other sizes: Other sizes available
Price: € 3257.00
Expected delivery time: 7 days

Product specifications for - InVivoMab anti-mouse PD-L1 (B7-H1)

Promotion: The price displayed is only for academic or non-profit organizations. Please contact our helpdesk for regular prices.
Product group: Antibodies
Category: Primary Antibodies
Application: Flow Cytometry; ImmunoFluorescence; ImmunoHistoChemistry; ImmunoHistoChemistry Frozen; Neutralisation/Blocking
Host: Rat
Clonality: Monoclonal
Isotype: IgG2b Kappa
Molecular weight: 150 kDa
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Concentration: 2-10 mg/ml
Scientific information: 
Clone ID: 10F.9G2
Related products: 
Related products: Recommended Isotype Control(s): InVivoMab rat IgG2b isotype control (BE0090)
Recommended Dilution Buffer: InVivoPure pH 6.5 Dilution Buffer (IP0065)
Additional information: 
Synonyms: 10F.9G2; BE0101; B7-H1 / PD-L1 / CD274; CD274; PDL1; PDCD1LG1; PDCD1L1; PD-L1; B7H1; B7-H; programmed death ligand 1; programmed cell death 1 ligand 1; PDCD1 ligand 1; CD274 antigen; B7 homolog 1; CD274 molecule; BioXCell
Ngiow SF, Young A, Jacquelot N, et al. A Threshold Level of Intratumor CD8+ T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1. Cancer Res. 2015;75(18):3800-11. Read more
Tkachev V, Goodell S, Opipari AW, et al. Programmed death-1 controls T cell survival by regulating oxidative metabolism. J Immunol. 2015;194(12):5789-800. Read more
Zander RA, Obeng-adjei N, Guthmiller JJ, et al. PD-1 Co-inhibitory and OX40 Co-stimulatory Crosstalk Regulates Helper T Cell Differentiation and Anti-Plasmodium Humoral Immunity. Cell Host Microbe. 2015;17(5):628-41. Read more
Twyman-saint victor C, Rech AJ, Maity A, et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature. 2015;520(7547):373-7. Read more
Jaworska K, Ratajczak J, Huang L, et al. Both PD-1 ligands protect the kidney from ischemia reperfusion injury. J Immunol. 2015;194(1):325-33. Read more
Dolina JS, Braciale TJ, Hahn YS. Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice. Hepatology. 2014;59(4):1351-65. Read more
Yang X, Zhang X, Fu ML, et al. Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses. Cancer Cell. 2014;25(1):37-48. Read more
Deng L, Liang H, Burnette B, et al. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest. 2014;124(2):687-95. Read more
Dietze KK, Zelinskyy G, Liu J, Kretzmer F, Schimmer S, Dittmer U. Combining regulatory T cell depletion and inhibitory receptor blockade improves reactivation of exhausted virus-specific CD8+ T cells and efficiently reduces chronic retroviral loads. PLoS Pathog. 2013;9(12):e1003798. Read more
Rutigliano JA, Sharma S, Morris MY, et al. Highly pathological influenza A virus infection is associated with augmented expression of PD-1 by functionally compromised virus-specific CD8+ T cells. J Virol. 2014;88(3):1636-51. Read more